Hoffmann-La Roche Ltd (Roche) is a world leader in biotechnology and a top provider of in-vitro diagnostics and other innovative healthcare solutions. The company strives to develop healthcare solutions for cardiometabolic diseases, inflammatory bowel diseases, hematologic disorders, infectious diseases, cancer, neurological disorders, respiratory diseases, gynaecological diseases, and ophthalmic diseases. To develop new solutions that help patients live longer and lead better lives, the company endeavours to strengthen its R&D efforts and enter into partnerships with external players. The company offers its products and services to hospitals, commercial laboratories, healthcare professionals, researchers, and pharmacists.